Indraprastha Medical Corporation Cash Flow
- Market cap
- ₹3,025 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹237.60 – ₹445.50
In the year ended FY25, Indraprastha Medical Corporation generated ₹182 crore from operating activities, invested ₹121 crore and paid out ₹45.38 crore on financing activities. Net cash flow for the year was ₹15.13 crore. Free cash flow was ₹75.63 crore.
Indraprastha Medical Corporation cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 182 |
| Cash from investing activities | -121 |
| Cash from financing activities | -45.38 |
| Net cash flow | 15.13 |
| Capital expenditure | 106 |
| Free cash flow | 75.63 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Indraprastha Medical Corporation cash flow — frequently asked questions
What is Indraprastha Medical Corporation's operating cash flow?
Indraprastha Medical Corporation's cash flow from operating activities was ₹182 crore in the year ended FY25.
What is Indraprastha Medical Corporation's free cash flow?
Indraprastha Medical Corporation's free cash flow — operating cash flow minus capital expenditure — was ₹75.63 crore in FY25, after capital expenditure of ₹106 crore.
How much did Indraprastha Medical Corporation spend on investing activities?
Net cash used in investing activities was ₹121 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Indraprastha Medical Corporation With ATS
Track INDRAMEDCO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.